EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-243.39M
↓ 290% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-62.35M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-243.39M | -86.8% |
| 2024 | $-130.28M | -8001.9% |
| 2023 | $-1.61M | +97.6% |
| 2022 | $-67.16M | -33.6% |
| 2021 | $-50.25M | -239.6% |
| 2020 | $-14.80M | +74.0% |
| 2019 | $-56.91M | -158.5% |
| 2018 | $-22.02M | -6.7% |
| 2017 | $-20.64M | -25.6% |
| 2016 | $-16.43M | - |